Prevelance of Dental Caries in Agroup of Egyption Children Using Caries Assessment Spectrum and Treatment
Sponsor
Cairo University (Other)
Overall Status
Unknown status
CT.gov ID
NCT04285931
Collaborator
(none)
250
15
Study Details
Study Description
Brief Summary
To explore the prevalence of dental caries in Egyptian children aged from 6 to 9 years oldusing CAST index and DMFT index
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
To explore the prevalence of dental caries in Egyptian children aged from 6 to 9 years oldusing CAST index and DMFT index. from MUST university outpatient clinic
Study Design
Study Type:
Observational [Patient Registry]
Anticipated Enrollment
:
250 participants
Observational Model:
Ecologic or Community
Time Perspective:
Cross-Sectional
Official Title:
Prevelance of Dental Caries in Agroup of Egyption Children Using Caries Assessment Spectrum and Treatment
Anticipated Study Start Date
:
Mar 1, 2020
Anticipated Primary Completion Date
:
Aug 1, 2020
Anticipated Study Completion Date
:
Jun 1, 2021
Outcome Measures
Primary Outcome Measures
- Prevelance of caries using dmft index [3month]
MDFT index
Secondary Outcome Measures
- Prevelance of caries index using cast index [3 month]
CAST index
Eligibility Criteria
Criteria
Ages Eligible for Study:
6 Years
to 9 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
- Parental or guardian acceptance for participation in the study.
-
Children who are medically free from any systemic diseases.
-
Children with mixed dentition aging from 6-9 years old.
-
Both genders.
Exclusion Criteria:
- uncooperative patient
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Cairo University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Esraa Sabry,
demosrator,
Cairo University
ClinicalTrials.gov Identifier:
NCT04285931
Other Study ID Numbers:
- Caries index
First Posted:
Feb 26, 2020
Last Update Posted:
Feb 26, 2020
Last Verified:
Feb 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: